ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349 | -83.6% | 109,990 | -74.3% | 0.00% | -82.4% |
| Q2 2023 | $2,126 | -36.3% | 427,752 | -36.7% | 0.02% | -39.3% |
| Q1 2023 | $3,336 | -54.2% | 675,279 | -41.7% | 0.03% | -73.6% |
| Q4 2022 | $7,288 | -99.7% | 1,158,701 | +419.0% | 0.11% | +231.2% |
| Q3 2022 | $2,411,000 | +592.8% | 223,241 | +631.9% | 0.03% | +700.0% |
| Q2 2022 | $348,000 | -22.7% | 30,503 | -38.2% | 0.00% | -33.3% |
| Q1 2022 | $450,000 | -77.5% | 49,360 | -63.2% | 0.01% | -71.4% |
| Q4 2021 | $2,004,000 | +516.6% | 134,300 | +976.6% | 0.02% | +425.0% |
| Q2 2021 | $325,000 | -12.6% | 12,475 | +18.4% | 0.00% | -20.0% |
| Q1 2021 | $372,000 | – | 10,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |